Dr. Bhooshan Zade is a post graduate in Radiation Oncology from the prestigious Tata Memorial Hospital, Mumbai.
1) Platinum SPARK: Protocol No. P276-00/64/11 “A Multicenter, Phase II/III Study to Assess Radiation Induced Mucositis in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck Administered Cisplatin and Radiation with or without P276-00 .
2) Protocol :-RC/0111/009 : A Multicentre ,randomized,open label,single dose,two treatment, three period, three sequence,partial,replicate,cross- over ,pivotal bioequivalence,study of test capacitabine 500 mg tablet manufactured by Reliance life Sciences .pvt.Ltd., India with Xeloda (Capacitabine 500 mg ) manufactured by Roche Pharma, AG , Germany in adult, human cancer patients under fed condition.
3) BI LUX- Head & Neck 2: A randomized, double blind, placebo- controlled, phase III study to evaluate the efficacy and safety of afatinib (BIBW 2992) as adjuvant therapy after chemo-radiotherapy in primary unresected patients with stage III, IVa or IVb loco-regionally advanced head and neck squamous cell carcinoma.